Doxorubicin Liposomal (Myocet)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Doxorubicin Liposomal (Myocet), covering 2011-10-13 to 2011-10-13. Get the full timeline:
Most recent: Clinical Trial Update: Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma [Phase 2]